P2Y12 Antiplatelet Choice for Patients with Chronic Kidney Disease and Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
P2Y12 Antiplatelet Choice for Patients with Chronic Kidney Disease and Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Journal of Personalized Medicine
Volume 11, Issue 3, Pages 222
Publisher
MDPI AG
Online
2021-03-22
DOI
10.3390/jpm11030222
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry
- (2020) Felice Gragnano et al. Internal and Emergency Medicine
- 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2020) Jean-Philippe Collet et al. EUROPEAN HEART JOURNAL
- Safety of Dual‐Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease
- (2019) Jennifer A. Rymer et al. Journal of the American Heart Association
- Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention
- (2019) Philip Urban et al. CIRCULATION
- Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function
- (2018) Robert Edfors et al. HEART
- Meta-Analysis of Potent P2Y12-ADP Receptor Antagonist Therapy Compared to Clopidogrel Therapy in Acute Coronary Syndrome Patients with Chronic Kidney Disease
- (2018) Marc Laine et al. THROMBOSIS AND HAEMOSTASIS
- The pharmacodynamics of low and standard doses of ticagrelor in patients with end stage renal disease on hemodialysis
- (2017) Jin Sug Kim et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
- (2017) Usman Baber et al. JACC-Cardiovascular Interventions
- Impact of chronic kidney disease on platelet inhibition of clopidogrel and prasugrel in Japanese patients
- (2017) Takeshi Nishi et al. Journal of Cardiology
- Chronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study
- (2017) G. Ocak et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Impact of residual platelet reactivity under clopidogrel treatment for lesions and the clinical outcome after drug-eluting stent implantation in patients with hemodialysis
- (2016) Akihide Konishi et al. Journal of Cardiology
- 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
- (2016) Glenn N. Levine et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- Platelet Reactivity After Receiving Clopidogrel Compared With Ticagrelor in Patients With Kidney Failure Treated With Hemodialysis: A Randomized Crossover Study
- (2015) Kyung Hwan Jeong et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- High Clopidogrel Dose in Patients With Chronic Kidney Disease Having Clopidogrel Resistance After Percutaneous Coronary Intervention
- (2014) Jing Liang et al. ANGIOLOGY
- PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews
- (2014) Abigail M Methley et al. BMC HEALTH SERVICES RESEARCH
- Triple vs. Dual Antiplatelet Therapy in Patients With Acute Myocardial Infarction and Renal Dysfunction
- (2013) Young Hwan Choi et al. CIRCULATION JOURNAL
- Impact of Clopidogrel Loading Dose in Patients With Chronic Kidney Disease Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
- (2012) Joon Young Kim et al. AMERICAN JOURNAL OF CARDIOLOGY
- Association of Estimated GFR With Platelet Inhibition in Patients Treated With Clopidogrel
- (2012) Clotilde Muller et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Options to Overcome Clopidogrel Response Variability
- (2012) Kyung Woo Park et al. CIRCULATION JOURNAL
- Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: Results of the Effect of Platelet Inhibition According to Clopidogrel Dose in Patients with Chronic Kidney Disease (PIANO-2 CKD) randomized study
- (2011) Jong Shin Woo et al. AMERICAN HEART JOURNAL
- Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?
- (2011) Terry K. W. Ma et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2011) R. C. Becker et al. EUROPEAN HEART JOURNAL
- Antiplatelet effects of prasugrel vs. double clopidogrel in patients on hemodialysis and with high on-treatment platelet reactivity
- (2011) D. ALEXOPOULOS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function
- (2010) Stefan James et al. CIRCULATION
- Impact of Cytochrome P450 2C19 Loss-of-Function Polymorphism and of Major Demographic Characteristics on Residual Platelet Function After Loading and Maintenance Treatment With Clopidogrel in Patients Undergoing Elective Coronary Stent Placement
- (2010) Willibald Hochholzer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Comparison of Clopidogrel Responsiveness in Patients With Versus Without Chronic Renal Failure
- (2009) Sang Hyun Park et al. AMERICAN JOURNAL OF CARDIOLOGY
- Variability in Responsiveness to Oral Antiplatelet Therapy
- (2009) Dominick J. Angiolillo AMERICAN JOURNAL OF CARDIOLOGY
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clopidogrel response variability: Current status and future directions
- (2009) José Luis Ferreiro et al. THROMBOSIS AND HAEMOSTASIS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started